Why Choose Private Prescription for Weight Management?
Private vs NHS Routes: Mounjaro vs Wegovy UK Access
The NHS pathway for weight management medications typically requires a GP referral to specialist services, followed by a 6+ month waiting period and strict eligibility criteria. Private prescription eliminates these barriers entirely. Through EverydayMeds, you can access both Mounjaro and Wegovy without GP referral, lengthy assessments, or specialist appointments. Our streamlined process takes just 3 minutes for the clinical assessment, followed by prescriber review within 24-48 hours for express service.
Both medications are prescription-only medicines that require clinical oversight, whether accessed privately or through the NHS. The key difference lies in speed and convenience. Private prescription allows you to begin treatment within days rather than months, whilst receiving the same genuine medications. Our GPhC-registered pharmacy (#9012878) ensures you receive authentic Wegovy manufactured by Novo Nordisk, not compounded alternatives.
Mounjaro vs Wegovy UK Pricing: Complete Cost Breakdown
Wegovy pricing starts at £79.99 for the 0.25mg starter dose (after FIRST40 discount for new customers), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenience for multi-month supply, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, covering your first 12 weeks. Returning customers benefit from the DOSE25 discount code applied at checkout.
Mounjaro pricing follows a different structure, reflecting its dual-action mechanism as both GIP and GLP-1 receptor agonist. Both treatments represent significant private healthcare investments, but eliminate NHS waiting times and provide immediate access to weight management support. The cost per month varies depending on your prescribed dose and treatment stage, with maintenance phases typically requiring higher investment than initial titration periods.
Clinical Evidence: Mounjaro vs Wegovy UK Trial Data
Wegovy demonstrated significant efficacy in the landmark STEP trials programme. In STEP 1, patients achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, when taking Wegovy alongside diet and exercise modifications. The STEP 2 trial showed 9.6% weight reduction in patients with type 2 diabetes, whilst STEP 3 achieved 16% with intensive behavioural therapy support.
Mounjaro's clinical evidence comes from the SURMOUNT trials, showing the dual GIP+GLP-1 mechanism may offer additional benefits. However, direct head-to-head comparisons between the two medications aren't available, as trials used different populations and endpoints. Both medications require commitment to lifestyle changes and represent prescription-only treatments requiring medical supervision throughout the treatment journey.
How Wegovy Works: Understanding GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. It works on appetite centres in the brain, potentially reducing food cravings and promoting earlier satiety during meals. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness. Unlike Mounjaro's dual-action approach, Wegovy focuses specifically on GLP-1 pathways. This targeted mechanism has been extensively studied through the STEP trial programme, demonstrating consistent weight management benefits when used alongside reduced-calorie diets and increased physical activity. The once-weekly injection schedule supports treatment adherence compared to daily medications.
Mounjaro vs Wegovy UK Ordering Process Explained
Our private prescription process begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. This information is reviewed by our qualified prescribers, typically within 3 working days for standard service or 24 hours for express review. Once approved, your medication is dispatched via next-day delivery using cold-chain transport to maintain temperature integrity. The entire process from assessment to delivery typically takes 2-5 days, dramatically faster than NHS specialist referral pathways. Both Mounjaro and Wegovy require the same clinical oversight, ensuring appropriate patient selection and ongoing monitoring throughout treatment.
Storage and Practical Differences: Mounjaro vs Wegovy UK
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, versus Mounjaro's 21-day limit. Both medications require refrigeration at 2-8°C before first use and come in pre-filled FlexTouch pen devices for easy self-injection. Wegovy follows a mandatory dose escalation schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This gradual increase helps minimise gastrointestinal side effects whilst optimising therapeutic response. The longer room temperature stability makes Wegovy more practical for travel and reduces wastage from temperature excursions.
Private Prescription Advantages: Mounjaro vs Wegovy UK Availability
Private prescription eliminates the postcode lottery affecting NHS weight management services across different UK regions. Some areas have minimal specialist provision, whilst others maintain 12+ month waiting lists for initial consultations. Through private prescription, geographical location becomes irrelevant — the same clinical standards and medication quality apply whether you're in London, Manchester, or rural Scotland.
Both Mounjaro and Wegovy are available through our private prescription service, giving you choice based on clinical suitability rather than NHS formulary restrictions. Private prescription also allows for more flexible dosing discussions and individualised treatment plans. Your prescriber can consider factors like lifestyle, travel requirements, and personal preferences when recommending between the two options, rather than being constrained by local commissioning decisions.
Making Your Choice: Mounjaro vs Wegovy UK Private Prescription
Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you based on your individual circumstances, medical history, and treatment goals. The decision often comes down to mechanism preference (single vs dual-action), storage requirements, and clinical suitability rather than superiority of one over the other. Our clinical team considers factors including your previous treatment response, lifestyle requirements, and any relevant medical conditions when making recommendations. New customers can use discount code FIRST40, whilst returning patients apply DOSE25 at checkout to access our competitive private prescription pricing. Start your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to begin your weight management journey without NHS delays.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
